Every biopharmaceutical product rests on a cell line, and every cell line rests on a cryogenic holding. The master cell bank (MCB) is the single, fully characterised source inventory. From it, working cell banks (WCB) are derived, and from those each production run begins.
Losing a working cell bank costs time and money. Losing a master cell bank can end an approved product — because the cell line cannot be reconstituted in its characterised, regulator-accepted form.
That asymmetry determines how cell banks must be stored.
Different storage requirements follow. The MCB is an archive holding with minimal access frequency and maximum safety requirements. The WCB is a working holding with high access frequency. The two do not belong in the same tank — not because of temperature, but because of opening cycles.
Every withdrawal from the WCB tank is a heat input. If the MCB sat in the same vessel, the company's most valuable holding would carry the thermal load of routine operations.
For master cell banks, geographically separated dual storage is both a regulatory expectation and a commercial necessity: part of the vials at the manufacturing site, a second part at a physically separate location.
A single event — fire, flood, extended power failure, building closure — must never be able to reach both holdings. "A different room in the same building" does not meet this requirement.
Three points decide whether it works in practice:
For cell banks the answer is unambiguous: storage is at –196 °C in liquid nitrogen, below the glass transition temperature of roughly –130 °C.
Above that threshold, water remains molecularly mobile and recrystallisation and slow degradation continue. For a master cell bank that must stay genetically stable and viable across the full product lifetime — frequently twenty years or more — that is not acceptable.
A second point is often overlooked: in a power failure, a compressor system fails immediately. A cryogenic tank does not. Thermal inertia and the nitrogen already in the tank carry it for hours to days — enough time to respond. For a company's most valuable holding, that is a structural advantage.
Consarctic® supplies the BSD+ series (stainless steel cryogenic tanks for long-term storage, scalable to 100,000 cryovials) and the BSF+ series (up to 1,700 × 500 ml bags). The eccentric tank opening lowers vapor-phase temperature, flattens the vertical gradient and cuts LN₂ consumption by up to 30 % — a meaningful factor in risk-adjusted total cost of ownership for an archive holding with a twenty-year horizon.
A cell bank is only as good as the homogeneity of its vials. If vial 1 and vial 250 were frozen differently, the bank is not characterised. It is a collection.
The BIOFREEZE® SMARTLINE from Consarctic® is built for this case:
The record here is not a convenience feature. It is the evidence that every vial in the bank went through the same process.
For GMP cell bank storage, an inspector expects:
Consarctic GmbH supplies this documentation as part of commissioning, performed by certified technicians and available in English and German for global use. All systems are manufactured to GMP-compliant standards and certified to EN ISO 13485:2016 and ISO 9001:2015.
In operation, the Consarctic® Monitoring System provides continuous level and temperature surveillance with remote access and alarm forwarding — including across multiple sites. The 24/7 emergency service is available 365 days a year.
Pharmaceutical customers including Bayer, GSK and Roche, alongside contract developers and manufacturers such as Minaris Regenerative Medicine, work with this infrastructure.
The master cell bank is the single, fully characterised source inventory of a production cell line, typically 100 to 300 vials for the entire product lifetime. The working cell bank is expanded from one MCB vial and supplies routine manufacturing.
Because of differing access frequency. Every withdrawal from the working holding is a heat input into the tank. If the master cell bank sat in the same vessel, the irreplaceable archive holding would carry the thermal load of routine operations.
Because a master cell bank cannot be reconstituted. A single event such as fire, flood or an extended power failure must never be able to reach both holdings. Both sites must be equivalently qualified and monitored; a second room in the same building does not satisfy the requirement.
No. –80 °C is above the glass transition temperature of roughly –130 °C, so recrystallisation and slow degradation continue. A master cell bank must remain genetically stable and viable across the full product lifetime, often twenty years or more. That requires LN₂ storage at –196 °C.
IQ/OQ/PQ documentation for every storage system, temperature mapping of all released positions, gap-free temperature and fill-level records across the entire storage period, documented alarm history with an assessment of every deviation, calibration certificates for all measuring equipment, and change control documentation.
A master cell bank is the one holding in a company whose loss cannot be offset by money, time or people. The storage infrastructure behind it should reflect that: separated from the working holding, held at two sites, continuously monitored and fully qualified.
Laying down a new cell bank, or reviewing your existing storage concept? Consarctic GmbH plans, supplies, qualifies and supports complete cryogenic infrastructure for biopharmaceutical manufacturing — one accountable partner from first concept to a running, GMP-validated facility. Get in touch.